Direct retrovirus-mediated hepatic gene transfer results in permanent
gene expression; however, gene transfer requires surgical hepatectomy
(to stimulate cell division) and has been inefficient, We recently use
d recombinant adenovirus vectors that transiently expressed urokinase
from mouse hepatocytes to induce hepatocellular regeneration in place
of a partial hepatectomy, The adenovirus method allowed for five-fold
more efficient retrovirus transduction in vivo compared to the convent
ional partial hepatectomy approach, The major problem with the urokina
se-mediated hepatic regeneration was the transient secretion of urokin
ase into the bloodstream that led to hypocoagulation, To circumvent th
is side-effect, the urokinase protein was modified by adding amino-ter
minal and carboxy-terminal endoplasmic reticulum retention signals. Th
e recombinant urokinase molecules expressed from adenoviral vectors re
mained in hepatocytes, were enzymatically active, and resulted in simi
lar rates of hepatic regeneration as found with the secreted urokinase
. Modified urokinase-mediated liver regeneration was equally capable o
f allowing retrovirus-mediated gene transfer in vivo. Thus, the method
of direct retrovirus transduction of hepatocytes becomes clinically r
elevant as the technology becomes safer.